Semaglutide guidelines based on BMI may exclude at-risk Indians

1 month ago 1

ARTICLE AD BOX

Global semaglutide eligibility criteria based connected BMI whitethorn not bespeak Indian hazard patterns, perchance excluding high-risk patients who make cardiovascular illness astatine little assemblage weights |Image utilized for representational intent only | Photo Credit: AFP

The SELECT trial, led by A. Michael Lincoff and published successful The New England Journal of Medicine (2023), showed that once-weekly semaglutide reduced large cardiovascular events by 20% successful adults with a assemblage wide scale (BMI) of 27 oregon higher and pre-existing cardiovascular disease, but without diabetes. The proceedings enrolled 17,604 participants and tracked outcomes implicit astir 40 months.

But applying this BMI threshold successful India could exclude patients astatine risk, says Aditi Kantipuly, preventive medicine and nationalist wellness nonmigratory astatine McGill University and visiting student astatine the University of New Mexico.

Published - April 08, 2026 02:37 p.m. IST

Read Entire Article